AstraZeneca to support creation of Life Sciences Innovation Park in China

AstraZeneca is spearheading the creation of a new life sciences park, in Wuxi, China, that aims to nurture innovation by...

April 1, 2019 | Monday | News
Luye Pharma's Rykindo might be the first Chinese Innovative Drug to receive U.S. FDA approval

Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Administration for ...

March 29, 2019 | Friday | News
Transcenta to develop novel biotherapeutics for bone diseases

Transcenta Holding has announced that its wholly-owned subsidiary, HJB, has signed an exclusive agreement with Eli Lilly...

March 29, 2019 | Friday | News
PolyU develops unique electrostatically charged nanofiber

The Department of Mechanical Engineering of The Hong Kong Polytechnic University (PolyU) has recently developed an elect...

March 28, 2019 | Thursday | News
New laboratory opens simultaneously with CIPM in Changsha

Romaco China will open a processing laboratory for solid pharmaceuticals on the Truking campus in Changsha right on time...

March 28, 2019 | Thursday | News
RegeneRx, Lee's Pharm to accelerate RGN-259 development in China

RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repair and regenera...

March 27, 2019 | Wednesday | News
WuXi STA's new facility passes European MPA GMP inspection

STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - announces that its new drug product m...

March 27, 2019 | Wednesday | News
Medtronic launches MedTech innovation accelerator in Shanghai

Medtronic plc, the global leader in medical technology, has announced the launch of the Medtronic MedTech Innovation Acc...

March 28, 2019 | Thursday | News
Hong Kong has the fourth-lowest health & well-being score, finds a Cigna survey

Global health service company Cigna Corporation has released the results of its 2019 Cigna 360 Well-Being Survey - ...

March 27, 2019 | Wednesday | News
WuXi Biologics wins recognition for bioprocessing capabilities

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

March 26, 2019 | Tuesday | News
HitGen, Almirall to identify novel drug targets

HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small mo...

March 26, 2019 | Tuesday | News
Huakang Biomed declares first annual results since listing

Huakang Biomedical Holdings Company Limited, a medical device group specialised in the research and development, manufac...

March 26, 2019 | Tuesday | News
Sosei announces launch of COPD medication in China

Sosei Group Corporation confirms that Ultibro® Breezhaler® and Seebri® Breezhaler® have been launched by...

March 25, 2019 | Monday | News
Research from XJTLU advances RNA modification mapping

Researchers from Xi'an Jiaotong-Liverpool University have completed a high-resolution prediction of the whole-transcript...

March 22, 2019 | Friday | News
Miltenyi, ATLATL build cell, gene therapy centre in Shanghai

To accelerate the development of cell and gene therapy, ATLATL centre and Miltenyi Biotec have cooperated...

March 21, 2019 | Thursday | News
WuXi Biologics gets EMA GMP Certificates for Trogarzo

WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...

March 20, 2019 | Wednesday | News
MilliporeSigma, GenScript to stimulate cell and gene therapy industrialization in China

MilliporeSigma signs a non-binding Memorandum of Understanding with GenScript for a strategic alliance fo...

March 20, 2019 | Wednesday | News
Shineco expands to capture cannabis market

Shineco, a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and...

March 19, 2019 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls